Humana Inc. (HUM)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Humana Inc. keeps $2 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 6
in 33 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Humana’s adjusted EPS topped consensus while revenue edged above estimates in the second fiscal quarter of 2026, based on preliminary results reported July 29. Revenue reached about $40.9 billion, up 26% from about $32.4 billion a year ago and versus the about $40.6 billion consensus, while adjusted EPS of $7.61 beat the $7.26 estimate by 4.8% and improved from $6.27 a year ago. Net income climbed 27% to about $693 million from $545 million a year ago, with operating income at roughly $1.4 billion, gross margin near 14%, and operating margin about 3%. Operating cash flow was negative $426 million, and the company repurchased $1.0 million of stock and paid $107.0 million in dividends. Next-period consensus calls for EPS of -$0.22 on revenue of $40.82 billion.
About Humana Inc.
Humana Inc. (NYSE: HUM) is a U.S. health insurer and care-services company focused on medical coverage, related benefits, and healthcare support. It operates in the healthcare sector through health plans and services, and generated $129.7 billion in revenue in FY2025.
Today's Snapshot
HUM closed 2.3% higher at 388.36, while its sector was flat. Volume was about two-thirds of its usual level. Humana cut its Medicare Advantage plan offerings for 2027.
Trading Volume
Below 10d avg (1.2M)
755.9K
vs S&P 500 Today
Outperforming Market
+1.51%
Updated: October 2, 2026 at 20:18 UTC
HUM Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$312.41 - $387.15Buy
- RSI (14)50.65Neutral
- Stochastic %K (14, 3, 3)30.85Neutral
- MACD Level (12, 26)-1.38Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.